Poland· PL-100377842

Imatilek

A imatinib product containing imatinibum, registered in Poland by Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.

ATC L01XE01

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about imatinibumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Imatinib is registered in 4 of 19 countries.

Countries holding a registration under ATC L01XE01 (imatinib), each read from that country’s own register.

This record: Poland, from URPL (Poland)
3 of them publish a price we can compare per daily dose

Search imatinib products by name

Imatinib · ATC L01XE01

4 / 19 countries

Belgiumprice
Ireland
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)

Active substance: Imatinibum
Manufacturer: Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
Country: Poland (PL)
ATC code: L01XE01
ATC class: Imatinib
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 8

gtin
05909991392529
gtin
05909991392536
gtin
05909991392543
gtin
05909991392550
gtin
05909991392567
gtin
05909991392574
gtin
05909991392581
gtin
05909991392598

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

770 interactions on record for imatinib.

Graded by severity as the source publishes them — 114 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check imatinib against other medicines How interaction checks work

Imatinib · interactions on record

770 records

114 severe
518 moderate
23 minor
111 info

Most severe, free to view

CisaprideA03FA02severe
NaloxegolA06AH03severe
EliglustatA16AX10severe
LonafarnibA16AX20severe

4 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Imatinib in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imatinib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Imagerolan, Imatinib 1a Pharma
Belgium · Imatinib Eg, Imatinib Grindeks
Bulgaria · Иматиниб Тева Фарма, Меаксин
Cyprus · Imarem, Imatinib Koanaa 100 Mg
Czechia · Imanivec, Imatinib Grindeks
Germany · Imanivec, Imatinib 1 A Pharma
Denmark · Bimatix, Imatinib "sandoz"
Estonia · Glipox, Imatinib Grindeks
Spain · Imatinib Cipla, Imatinib Farmalider
Finland · Bimatix, Imatinib Hexal
France · Imatinib Arrow Lab, Imatinib Bgr
United Kingdom (Northern Ireland) · Imatinib, Imatinib Amarox
Greece · Imatek, Imatinib Aenorasis
Croatia · Imakrebin, Meaxin
Hungary · Imaniver, Imatinib 1 A Pharma
Ireland · Imatinib Krka D.D., Imatinib Rowex
Iceland · Bimatix, Glivec
Italy · Imanivec, Imatinib Dr. Reddy’s
Liechtenstein · Glivec, Imatinib Accord
Lithuania · Glipox, Imatinib Grindeks
Luxembourg · Imatinib, Imatinib Eg
Latvia · Imatinib Grindeks, Imatinib Inteli
Malta · Imatinib Tad, Nibix
Netherlands · Bimatix, Imakrebin
Norway · Bimatix, Glivec
Portugal · Imatinib Aurobindo, Imatinib Aurovitas
Romania · Imakrebin, Imatinib Grindeks
Sweden · Bimatix, Imatinib Amarox
Slovenia · Meaxin
Slovakia · Imatinib Glenmark, Imatinib Grindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f4dce65b-7ef6-4c15-a72f-9b6d9333ddfd
GET /v1/drugs/f4dce65b-7ef6-4c15-a72f-9b6d9333ddfd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "05909991392529 ¦ Rpz ¦ 130941\n10 kaps.\n05909991392536 ¦ Rpz ¦ 130942\n20 kaps.\n05909991392543 ¦ Rpz ¦ 130943\n30 kaps.\n05909991392550 ¦ Rpz ¦ 130944\n60 kaps.\n05909991392567 ¦ Rpz ¦ 130945\n90 kaps.\n05909991392574 ¦ Rpz ¦ 130946\n100 kaps.\n05909991392581 ¦ Rpz ¦ 130947\n120 kaps.\n05909991392598 ¦ Rpz ¦ 130948\n180 kaps.",
  "substance": "Imatinibum 100 mg",
  "common_name": "Imatinibum",
  "pl_product_id": "100377842",
  "pozwolenie_nr": "25122",
  "auth_procedure": "NAR",
  "authorisation_validity": "2024-02-15"
}

API reference MCP server Plans

See everything about imatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console